Ignite Creation Date:
2024-05-06 @ 6:29 PM
Last Modification Date:
2024-10-26 @ 2:49 PM
Study NCT ID:
NCT05679479
Status:
COMPLETED
Last Update Posted:
2024-05-28
First Post:
2023-01-10
Brief Title:
Study on the Safety and Efficacy of Meplazumab for Injection in Severe Patients With COVID-19
Sponsor:
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd
Organization:
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-19
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-18
Completion Date Type:
ACTUAL
First Submit Date:
2023-01-10
First Submit QC Date:
January 10 2023
Study First Post Date:
2023-01-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-23
Last Update Post Date:
2024-05-28
Last Update Post Date Type:
ACTUAL